PTI-428-06: A Phase 2, Multicenter, Randomized, Double-Blind,Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect of PTI-428 inSubjects with Cystic Fibrosis

Project: Research project

Description

PTI-428-06: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect of PTI-428 in Subjects with Cystic Fibrosis
StatusFinished
Effective start/end date9/28/181/1/20

Funding

  • PROTEOSTASIS THERAPEUTICS, INC.

Fingerprint

Cystic Fibrosis
Pharmacokinetics
Placebos
Safety